Validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in a Chinese systemic lupus erythematosus cohort
The sensitivity and specificity of 2023 APS classification criteria varied depending on the scoring strategy used. Considering the presence of SLE as a distinct item in future APS classification criteria may be warranted.
Authors
- X Zhu
- Di Gao (ORCID: https://orcid.org/0000-0003-0493-8445)
- Lanlan Ji (ORCID: https://orcid.org/0000-0001-9620-8882)
- Ying Fan (ORCID: https://orcid.org/0000-0003-0189-9524)
- Zhenkai Fu
- Zhuohan Cao
- Hong Huang
- Wenhui Xie
- Zhuoli Zhang
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1097/cm9.0000000000003968
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00